Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
Variable enterovirus antibody titres in IVIG urge clinical caution on presumed efficacy; leaves open needs for standardization and outcome correlation.
N ijm egen , The N eth erla n d sA ntibod y titres in im m unoglobulin preparations fo r intravenous use w ere tested against 24 dif ferent enterovirus serotypes and varied betw een 1 : 100 and 1 : 10,000 w ithin a single batch.Dif ferences up to 8-fold w ere found for hom olo gous titres betw een tw o different batches that w ere prepared 6 years apart.The lowest titre ob tain ed w as 1 : 40.T he observed d iffe re n ce s w ith in and between the two batches could not be explained by different incidence of serotypes of enteroviruses circulating at the tim e blood w as collected.Differences in titres of up to 18fold w ere observed w hen several strains of the sam e serotype w ere tested suggesting that intratypic variation influences antibody titres.It is concluded that Im m unoglobulin prepara tions contain antibodies against m any en tero vi ruses, but that titres can be low and cannot be predicted from the incidence of any particular serotype circulating in the community.Because of intratypic variation, selection of a batch for specific treatm ent should be based on results obtained with the patient's own isolate, and not with a reference strain.
No takes yet. Share an insight, caveat, or question.
Galama et al. (1997) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: